A detailed history of Mather Group, Llc. transactions in Zoetis Inc. stock. As of the latest transaction made, Mather Group, Llc. holds 3,250 shares of ZTS stock, worth $574,405. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,250
Previous 3,527 7.85%
Holding current value
$574,405
Previous $611,000 3.76%
% of portfolio
0.01%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$172.58 - $196.48 $47,804 - $54,424
-277 Reduced 7.85%
3,250 $634,000
Q2 2024

Jul 08, 2024

BUY
$145.54 - $178.83 $83,394 - $102,469
573 Added 19.4%
3,527 $611,000
Q1 2024

Apr 08, 2024

BUY
$165.67 - $199.94 $1,325 - $1,599
8 Added 0.27%
2,954 $499,000
Q4 2023

Feb 05, 2024

SELL
$151.44 - $200.09 $104,796 - $138,462
-692 Reduced 19.02%
2,946 $581,000
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $12,201 - $14,072
73 Added 2.05%
3,638 $632,000
Q2 2023

Aug 08, 2023

BUY
$160.94 - $186.23 $195,863 - $226,641
1,217 Added 51.83%
3,565 $613,000
Q1 2023

May 09, 2023

SELL
$145.48 - $175.02 $928,307 - $1.12 Million
-6,381 Reduced 73.1%
2,348 $390,000
Q4 2022

Mar 10, 2023

BUY
$131.14 - $157.47 $142,418 - $171,012
1,086 Added 14.21%
8,729 $1.28 Million
Q3 2022

Nov 14, 2022

SELL
$148.29 - $182.55 $23,578 - $29,025
-159 Reduced 2.04%
7,643 $1.13 Million
Q2 2022

Aug 16, 2022

BUY
$155.97 - $200.09 $385,089 - $494,022
2,469 Added 46.3%
7,802 $1.34 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $89,062 - $114,908
-491 Reduced 8.43%
5,333 $1.01 Million
Q4 2021

Feb 15, 2022

BUY
$193.69 - $247.03 $277,557 - $353,993
1,433 Added 32.63%
5,824 $1.42 Million
Q3 2021

Nov 04, 2021

BUY
$189.29 - $209.69 $129,852 - $143,847
686 Added 18.52%
4,391 $852,000
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $208,750 - $251,718
1,339 Added 56.59%
3,705 $690,000
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $340,704 - $400,776
2,366 New
2,366 $373,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.